FMI Reveals Biomarker-driven Breakthroughs! Companion Diagnostic Tests Unlock Precision Treatment with PARP Inhibitors. The Industry Projected to surpass US$ 16,153.50 million by 2034 NEWARK, Del, March 20, 2024 (GLOBE NEWSWIRE) -- The PARP inhibitor market is anticipated to be worth US$ 6,279.90 million in 2024. The adoption of PARP inhibitors is likely to rise at a CAGR of...